<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7843251" created="28/05/2006" creator="Hitomi Masuda"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7843251</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="protein_kinase_C" sem="Protein_molecule">Protein kinase C</term> is not a downstream effector of <term id="T2" lex="p21ras" sem="DNA_domain_or_region">p21ras</term> in <term id="T3" lex="activated_T_cell" sem="Cell_natural">activated T cells</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E1">
<type class="Regulation"/>
<theme idref="T1"/>
<cause idref="T2"/>
<clue>Protein kinase C is <cluePolarity>not</cluePolarity> a <clueType>downstream effector</clueType> <linkTheme>of</linkTheme> p21ras <clueLoc>in activated T cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The aim of this present study was to investigate the role of <term id="T4" lex="protein_kinase_C" sem="Protein_molecule">protein kinase C</term> (<term id="T5" lex="PKC" sem="Protein_molecule">PKC</term>), downstream of <term id="T6" lex="p21ras" sem="DNA_domain_or_region">p21ras</term>, in activating <term id="T7" lex="interleukin-2_(IL-2)_gene_expression" sem="Other"><term id="T8" lex="interleukin-2_(IL-2)_gene" sem="DNA_domain_or_region">interleukin-2 (<term id="A1" sem="DNA_domain_or_region">IL-2</term>) <term id="A2" sem="DNA_domain_or_region">gene</term></term> expression</term>.</sentence>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="A1" idref1="A2"/>
<clue>The aim of this present study was to investigate the role of protein kinase C (PKC), downstream of p21ras, in activating interleukin-2 (IL-2) gene <clueType>expression</clueType>.</clue>
</event>
<event KT="Other" id="E100">
<type class="Regulation"/>
<theme idref="T5"/>
<cause idref="T6"/>
<clue>The aim of this present study was to investigate the role of protein kinase C (PKC), <clueType>downstream</clueType> <linkCause>of</linkCause> p21ras, in activating interleukin-2 (IL-2) gene expression.</clue>
</event>
<event KT="Investigation" id="E3" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T5"/>
<clue>The aim of this present study was <clueKT>to investigate</clueKT> the role of protein kinase C (PKC), downstream of p21ras, <linkCause>in</linkCause> <clueType>activating</clueType> interleukin-2 (IL-2) gene expression.</clue>
</event>
<sentence id="S3">It has been reported that <term id="T9" lex="PKC" sem="Protein_molecule">PKC</term> is an <term id="T10" lex="effector" sem="Protein_family_or_group">effector</term> of <term id="T11" lex="p21ras" sem="DNA_domain_or_region">p21ras</term> in <term id="T12" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event KT="Analysis" Source="Other" id="E4">
<type class="Correlation"/>
<theme idref="T9"/>
<theme idref="T11"/>
<clue>It <clueSource>has been</clueSource> <clueKT>reported</clueKT> that PKC is an <clueType>effector</clueType> <linkTheme>of</linkTheme> p21ras <clueLoc>in T cells</clueLoc>.</clue>
</event>
<sentence id="S4">Data is presented, using the potent and selective <term id="T13" lex="PKC_inhibitor" sem="Organic_compound_other"><term id="T14" lex="PKC" sem="Protein_molecule">PKC</term> inhibitor</term> <term id="T15" lex="Ro_31-8425" sem="Organic_compound_other">Ro 31-8425</term> and transient expression of a constitutively active ras mutant, which clearly shows that <term id="T16" lex="PKC" sem="Protein_molecule">PKC</term> is not downstream of <term id="T17" lex="p21ras" sem="DNA_domain_or_region">p21ras</term> in the induction of <term id="T18" lex="NF-AT" sem="Protein_molecule">NF-AT</term> and <term id="T19" lex="AP-1_transcriptional_activity" sem="Other"><term id="T20" lex="AP-1" sem="Protein_molecule">AP-1</term> transcriptional activity</term> and in the expression of <term id="T21" lex="IL-2" sem="Protein_molecule">IL-2</term> in <term id="T22" lex="human_Jurkat_T_cell" sem="Cell_cultured">human Jurkat T cells</term>.</sentence>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<cause idref="T18"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras in the induction of NF-AT and AP-1 <clueType>transcriptional activity</clueType> and in the expression of IL-2 in human Jurkat T cells.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<cause idref="T20"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras in the induction of NF-AT and AP-1 <clueType>transcriptional activity</clueType> and in the expression of IL-2 in human Jurkat T cells.</clue>
</event>
<event KT="Other" id="E7">
<type class="Gene_expression"/>
<theme idref="T21"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras in the induction of NF-AT and AP-1 transcriptional activity and in the <clueType>expression</clueType> <linkTheme>of</linkTheme> IL-2 <clueLoc>in human Jurkat T cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E400">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T17"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras in the induction of NF-AT and AP-1 transcriptional activity and <linkCause>in</linkCause> the expression of IL-2 in human Jurkat T cells.</clue>
<comment>No clueType</comment></event>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T17"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras in the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT and AP-1 transcriptional activity and <linkCause>in</linkCause> the expression of IL-2 <clueLoc>in human Jurkat T cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T17"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras <linkCause>in</linkCause> the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT and AP-1 transcriptional activity and in the expression of IL-2 <clueLoc>in human Jurkat T cells</clueLoc>.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E10">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="E400"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly <clueKT>shows</clueKT> that PKC is <cluePolarity>not</cluePolarity> <clueType>downstream</clueType> <linkTheme>of</linkTheme> p21ras in the induction of NF-AT and AP-1 transcriptional activity and in the expression of IL-2 in human Jurkat T cells.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E11">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="E8"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly <clueKT>shows</clueKT> that PKC is <cluePolarity>not</cluePolarity> <clueType>downstream</clueType> <linkTheme>of</linkTheme> p21ras in the induction of NF-AT and AP-1 transcriptional activity and in the expression of IL-2 in human Jurkat T cells.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E12">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="E9"/>
<clue>Data is presented, using the potent and selective PKC inhibitor Ro 31-8425 and transient expression of a constitutively active ras mutant, which clearly <clueKT>shows</clueKT> that PKC is <cluePolarity>not</cluePolarity> <clueType>downstream</clueType> <linkTheme>of</linkTheme> p21ras in the induction of NF-AT and AP-1 transcriptional activity and in the expression of IL-2 in human Jurkat T cells.</clue>
</event>
<sentence id="S5"><term id="T23" lex="reporter_gene_experiment" sem="Other">Reporter gene experiments</term> demonstrated that <term id="T24" lex="NF-kappa_B_transcriptional_activity" sem="Other"><term id="T25" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> transcriptional activity</term> is not affected by expression of activated <term id="T26" lex="p21ras" sem="DNA_domain_or_region">p21ras</term>.</sentence>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<clue>Reporter gene experiments demonstrated that NF-kappa B transcriptional activity is not affected by expression of <clueType>activated</clueType> p21ras.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<cause idref="T25"/>
<clue>Reporter gene experiments demonstrated that NF-kappa B <clueType>transcriptional activity</clueType> is not affected by expression of activated p21ras.</clue>
<comment>No corefTheme</comment></event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E15">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="E14"/>
<clue><clueExperiment>Reporter gene experiments</clueExperiment> <clueKT>demonstrated</clueKT> that NF-kappa B transcriptional activity is <cluePolarity>not</cluePolarity> <clueType>affected</clueType> <linkCause>by</linkCause> expression of activated p21ras.</clue>
</event>
<sentence id="S6">The signaling pathways involving <term id="T27" lex="PKC_activation" sem="Other"><term id="T28" lex="PKC" sem="Protein_molecule">PKC</term> activation</term>, <term id="T29" lex="calcium_mobilization" sem="Other"><term id="T30" lex="calcium" sem="Element">calcium</term> mobilization</term> and <term id="T31" lex="ras_activation" sem="Other"><term id="T32" lex="ras" sem="Protein_molecule">ras</term> activation</term> combine to provide the necessary components for production of <term id="T33" lex="IL-2" sem="Protein_molecule">IL-2</term> during <term id="T34" lex="T_cell_activation" sem="Other"><term id="A3" sem="Cell_natural">T cell</term> activation</term>.</sentence>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<clue>The signaling pathways involving PKC <clueType>activation</clueType>, calcium mobilization and ras activation combine to provide the necessary components for production of IL-2 during T cell activation.</clue>
</event>
<event id="E17">
<type class="Localization"/>
<theme idref="T30"/>
<clue>The signaling pathways involving PKC activation, calcium <clueType>mobilization</clueType> and ras activation combine to provide the necessary components for production of IL-2 during T cell activation.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<clue>The signaling pathways involving PKC activation, calcium mobilization and ras <clueType>activation</clueType> combine to provide the necessary components for production of IL-2 during T cell activation.</clue>
</event>
<event id="E19">
<type class="Physiological_process"/>
<theme idref="A3"/>
<clue>The signaling pathways involving PKC activation, calcium mobilization and ras activation combine to provide the necessary components for production of IL-2 during T cell <clueType>activation</clueType>.</clue>
</event>
<event id="E20">
<type class="Gene_expression"/>
<theme idref="T33"/>
<clue>The signaling pathways involving PKC activation, calcium mobilization and ras activation combine to provide the necessary components for <clueType>production</clueType> <linkTheme>of</linkTheme> IL-2 during T cell activation.</clue>
</event>
<event id="E200">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="E19"/>
<clue>The signaling pathways involving PKC activation, calcium mobilization and ras activation combine to provide the necessary components for production of IL-2 <linkCause>during</linkCause> T cell activation.</clue>
<comment>No clueType</comment></event>
<event id="E121">
<type class="Correlation"/>
<theme idref="E16"/>
<theme idref="E200"/>
<clue>The signaling pathways involving PKC activation, calcium mobilization and ras activation <clueType>combine</clueType> <linkTheme>to</linkTheme> provide the necessary components for production of IL-2 during T cell activation.</clue>
</event>
<event id="E221">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E200"/>
<clue>The signaling pathways involving PKC activation, calcium mobilization and ras activation <clueType>combine</clueType> <linkTheme>to</linkTheme> provide the necessary components for production of IL-2 during T cell activation.</clue>
</event>
<event id="E21">
<type class="Correlation"/>
<theme idref="E18"/>
<theme idref="E200"/>
<clue>The signaling pathways involving PKC activation, calcium mobilization and ras activation <clueType>combine</clueType> <linkTheme>to</linkTheme> provide the necessary components for production of IL-2 during T cell activation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
